Sudarshan Pharma Industries Limited at its board meeting held on November 10, 2023, based on the recommendation of the Nomination and Remuneration Committee, the Board has considered and approved appointment of Mr. Anil Balkrishna Ghogare (DIN: 00432659) as an Additional Director in the category of Non-Executive Director. Based on the recommendation of the Nomination and Remuneration Committee, the Board has considered and approved appointment of Mr. Nilesh Harish Thakkar (DIN: 10044097) as an Additional Director in the category of Non-Executive Director, with effect from November 10, 2023. Detail of Anil Balkrishna: His vision includes Create excellence in Technology, Facility design and GMP work culture through people, technology & teamwork in Pharmaceutical field.

Having Education background in Masters of Business Administration (M.B.A.), Finance M. S. University Baroda. Ph.D., Pharmaceutical Chemistry, Mumbai University. Masters of technology (M. Tech), Chemical & Instrumentation, Indian Institute of Technology(IIT), New Delhi.

Masters of Science (M. SC)., Organic Chemistry, Pune University. With Scientific Publications as 16 Nos in National and international scientific journals and 3Nos.Patents in Europe and USA. Presently working as Advisor, Directors in various Pharmaceutical companies and Promoter of M/S. Pharma-In-Future Technology and GMP/Regulatory consultant and having following subsidiaries for design of plant, technology transfers, regulatory support.

His awards and Recognitions include Member of International Association of Business Leaders Inc.; New Bern, NC 28561, USA. Member of Board of Studies, MS University, Baroda for Environment Science. Member of Indian Chemical Society.

Member of Alumni Association, Indian Institute of Technology, New Delhi. Having 37 years' experience worked on various Fermenation Technology. Handled more than 250 API from development to scale-up and Regulatory Approvals.

Formulation and Regulatory Approval. Having own CRO for formulation development with Skilled and experienced scientist and pharmacist for New Drug Delivery systems worked in various extended release, sustained release tablets, capsules patches, granules, injectables with clinical studies and equivalence studies with RLD. Set-up various very low humidity control API and Formulation facility with 18-20% humidity like Clavulanic acid, Amoxicillin Clavulanic acid tablets, Effervescent tablets and dispersible tablets and Lyophillization injections for Oncology and cephalosporins.

Set-up high Potent FDF like Oncology OSD and Injectable, Steroids, Hormones OSD, Injectable, and inhalers, Penicillin and Cephaolsporin sterile injections EU GMP ICH Q7 GMP AUDITOR and audited in India, China and Europe 49 nos audits for MNC vendor approvals. Details of Nilesh Harish Thakkar: Having more than 35 years of experience in the International trade with the wide product portfolio in their basket. He has gained rich experience in the respective areas by working at the grassroot levels at both production as well as in the market and thereby, possess the deep understanding of the customer's exact requirements which helps to build long lasting relationships with their business partners.

The seasoned experience of the team backed by their customer centric attitude and approach have resulted in expansion of the business in various countries across the world. In 2014, expanded its operations to the Middle East and Africa regions, with a broader vision of capturing new markets. The strong distribution network enables it to reach customers in even the most remote locations,ensuring that they always have access to the products they need.

Known for its wide range of products, including sugar, rice, tomato paste, canned foods, milk products, cooking oils, bakery items & confectionery, petroleum products, cars, tyres, construction materials. Has established long-term relationships with suppliers from different parts of the world, such as India, China, Hong Kong, Italy, Dubai, USA, Canada, Kenya, Uganda, South Africa, and Tanzania.